Corvus Pharma Com (CRVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Operating Expenses | 43,760 | 48,854 | 49,222 | 56,524 | 36,976 |
| Operating Income | -43,760 | -48,854 | -49,222 | -56,524 | -36,976 |
| Other Income | 37,765 | 2,182 | 2,283 | 861 | 601 |
| Pre-tax Income | -5,995 | -46,672 | -46,939 | -55,663 | -36,375 |
| Net Income Continuous | -5,995 | -46,672 | -46,939 | -55,663 | -36,375 |
| Net Income | $-5,995 | $-46,672 | $-46,939 | $-55,663 | $-36,375 |
| EPS Basic Total Ops | -0.20 | -1.59 | -1.71 | -2.72 | -2.36 |
| EPS Basic Continuous Ops | -0.20 | -1.59 | -1.71 | -2.72 | -2.36 |
| EPS Diluted Total Ops | -0.20 | -1.59 | -1.71 | -2.72 | -2.36 |
| EPS Diluted Continuous Ops | -0.20 | -1.59 | -1.71 | -2.72 | -2.36 |
| EPS Diluted Before Non-Recurring Items | -1.47 | -1.59 | N/A | N/A | N/A |
| EBITDA(a) | $-42,974 | $-48,755 | $-48,983 | $-55,877 | $-35,734 |